Simplex Trading, LLC Dbv Technologies S.A. Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 14, 2020	SELL	$1.58 - $4.77 $158 - $476	-100 Closed	0 $0
Q1 2020 Apr 29, 2020	BUY	$2.33 - $12.98 $233 - $1,298	100 New	100 $0
Q4 2017 Jan 10, 2018	SELL	$20.9 - $49.36 $178,109 - $420,645	-8,522 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$39.62 - $46.17 $337,641 - $393,460	8,522	8,522 $361,000

3.2K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $774M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.